RE: Nice16 Jul 2020 10:29
simple fact is when NSF was 8/7/6/5p no one paid attention.
the trading statement was inline with business space they operate in, just like MCL, IPF, AMGO. They lend to people, thats the business. so when accountants/auditors report, they will show the lended sum goes under liability which is classed as expenses, i.e debt in simple terms. I work in finance.
The point the company have been deeply annoyed with delay in releasing the trading update for nearly 2months becasue of covid as it stopped them from carrying on when i got in touch with company. This was further backed when directors , may i most of them, bought around 7/8p levels and thought the market had over reacted. since trading statement NSF continued to say they are working major holders to get additional funding not to serve debts but to increase business exposure and acquisitions.
so it is not like they dont have money, as yesterdays news tells they made £12mil cash in June alone and have £72mil cash in the bank with borrowing facilities also.
stressed seller has caused this short term drop which is a gift. so take up, because this is going to director buy levels for a start and 10/11p settle before any other news.
also only 30% shares avaialble on market to trade. hence the vast price movement.
I'm trying to help you everybody make money and DYOR. but you will see my point how undervalued this company is.
Few years ago, this was targeted a TO at £1billion